Pro Dex (PDEX) Short term Debt (2011 - 2022)
Pro Dex's (PDEX) quarterly Short term Debt came in at $1.6 million in Q1 2022, up 30.32% quarter-over-quarter from $1.3 million in Q4 2021.
Analysis
Pro Dex (PDEX) Short term Debt (2011 - 2022) Analysis & Trends
Pro Dex has disclosed Short term Debt across 4 years of filings, most recently posting $1.6 million for Q1 2022.
- In Q1 2022, Short term Debt changed N/A year-over-year to $1.6 million; the TTM figure through Mar 2022 stood at $1.6 million (changed N/A YoY), while the FY2021 annual figure was $1.2 million, changed N/A from the prior year.
- Short term Debt came in at $1.6 million for Q1 2022 at Pro Dex, up from $1.3 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.6 million in Q1 2022 to a low of $1.2 million in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Pro Dex | 192.84 Mn | 183.45 Mn | 7.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 1.24 Mn |
| Jun 30, 2012 | 774,000.00 |
| Mar 31, 2012 | 357,000.00 |
| Dec 31, 2011 | 357,000.00 |
| Sep 30, 2011 | 357,000.00 |
| Jun 30, 2011 | 357,000.00 |